LUXFER HOLDINGS PLC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LUXFER HOLDINGS PLC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	415	441	402	373	325	374	423	405	392	385
Cost of revenue	320	333	284	270	244	278	328	328	306	295
Gross profit	94.6	109	118	104	80.9	96	95	76.6	85.7	89.2
Research and development	7.6	7.8	6.3	5.7	3.3	3.9	4.9	4.6	4.4	4.3
Selling, general and administrative	56.2	68.1	54.6	49.7	39.8	47.3	43.1	48.7	48.1	49.1
General and administrative	50.8	58.9
Operating income	32.9	21.9	33.6	18.7	28.5	36.2	44.8	4.2	30.1	24
Interest expense	6.3	6.6	4.9	4.5	5	3.1	3.9	6.3	5.2	3.1
Interest income	0.3	0.3	0.4	0.1	0	0
Pre-tax income	24.1	19.8	33.8	15.6	27.8	35.4	41	-9.7	26.5	22.2
Income tax	6.8	3.3	6.5	7.6	6.9	5.4	9	-7.1	8.2	9.1
Income from continuing operations			27.7	8.7	20.8	30	32	-2.6	18.3	13.1
Net income	17.8	16.6	25	3.1	20	29.9	26.9	-1.9	18.4	7.7
EBITDA	50.9	40.2	50.5	31.9	41.8	51.8	58.4	16.9	40.2	33.9
EPS, basic	0.67	0.63	0.94	0.11	0.73	1.08	0.99	-0.07	0.69	0.29
EPS, diluted	0.67	0.62	0.90	0.11	0.72	1.07	0.98	-0.07	0.68	0.28
Shares, basic (weighted)	26.4	26.5	26.7	27.3	27.6	27.7	27.3	26.9	26.8	26.7
Shares, diluted (weighted)	26.7	26.7	27.7	27.9	28	28	27.5	27	27.1	27.2

Balance sheet

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	13.6	12.6	13.8	10.2	1.5	6.2	12.6	2.3	4.1	8.3
Short-term investments	0	1.6
Receivables	57.6	53.8	49.8	40.8	33.6	45.8	56.4	52.3	45.8	44.6
Inventory	82.5	82.2	93.6	77.6	68.8	90.5	111	95.9	83.6	92.4
Other current assets		1.2	10.7	1.1	1.5	0	0	1.5	0	5.4
Total current assets	156	171	181	189	151	163	201	169	176	164
Property, plant and equipment	129	129	107	90.2	86	87.5	77.7	63.8	62.8	60.2
Lease right-of-use assets			18.4	11	9.5	12.6	19.8	15.4	11.5	8.5
Goodwill	67.9	71.2	67.6	68.8	70.2	69.7	65.6	67.5	67	69.6
Intangible assets		16.1	14.6	13.6	12.8	13.7	12.5	12	11.5	10.9
Other non-current assets		0.3	0
Total assets	400	416	409	390	346	369	407	372	382	370
Accounts payable	51.1	28.4	36.9	30.2	18.6	31.7	37.8	26.5	29.6	24.6
Accrued liabilities		29.7	33.8	23.7	21.5	28.2	29.4	20.9	24	27.2
Deferred revenue										6.1
Short-term debt	0	19.2	3.5	0	0	0	25	4.6	3.1	25
Total current liabilities	54	84	91.2	77.5	65.4	83.9	110	64.8	93.7	98.2
Long-term debt		94.6	73.6	91.4	53.4	59.6	56.2	67.6	42	14.4
Lease liabilities			14.9	8.9	6.7	9.8	18.2	15	10.7	8
Other non-current liabilities		3.2	16.2	9.9	7.7	11.6	19	16.8	13.1	12.2
Total liabilities	250	241	225	216	179	160	200	160	163	143
Total debt	121	114	77.1	91.4	53.4	59.6	81.2	72.2	45.1	39.4
Paid-in capital	56.4	62.1	65.6	68.4	70.6	70.9	221	224	226	229
Retained earnings	308	83.7	95.3	84.8	91.2	108	120	104	109	103
Treasury stock	-7.1	-5.8	-4.3	-4	-4	-9.6	-20.4	-22.9	-24.9	-27.6
Other comprehensive income		-141	-147	-150	-166	-135	-139	-118	-116	-103
Shareholders' equity	150	175	184	174	167	209	207	213	220	226
Total equity	142	162	184	174	167	209	207	213	220	226
Total liabilities and equity	392	416	409	390	346	369	407	372	382	370
Shares outstanding							28.9	26.8	26.7	26.6

Cash flow statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	17.8	16.6	25	3.1	20	29.9	26.9	-1.9	18.4	7.7
Depreciation and amortization	18	18.3	16.9	13.2	13.3	15.6	13.6	12.7	10.1	9.9
Stock-based compensation	1.4	3.1	4.8	4.5	2.8	2.8	2.5	2.8	3.5	3.6
Deferred income tax	2.9	-2.7	-0.3	4	4.8	-2	9.8	-8	1.9	5.2
Change in receivables	-2.9	-11.5	5.7	-7.6	10.7	-9.8	-25.3	17.5	-4.3	4.3
Change in inventory	4.5	4.9	-14.5	3.5	9.5	-15.3	-25	16.6	-4.1	-6.7
Change in payables	-9	1.5	7.3	-0.7	-12.9	11.4	21.3	-19	4.8	-5.7
Cash from operations	20.6	38.8	63.2	5.8	49.6	26.1	15.9	26.3	51.1	34
Capital expenditures	-16.6	-10.5	-13.2	-13.1	-8	-9.1	-8.3	-9.4	-10.3	-7.8
Acquisitions	-0.3	-4.7	2.7	0	0	-19.3	0	0
Cash from investing	-12.5	-16	-10	-8.3	-6.8	-5.1	-5.7	-9.5	-3.4	-5.1
Debt issued								0	0	36.7
Debt repaid	-8.5	-13.4	-21.3					-25	0	-26.7
Stock issued	0	0	6.6	3.5	1.1	0	0
Share buybacks	-7.3	0	0	0	0	-6.4	-11.1	-2.7	-2.3	-3.1
Dividends paid	-13.3	-13.3	-13.4	-13.6	-13.6	-13.6	-14.2	-14	-14	-13.9
Cash from financing	-29.5	-25.1	-51.9	-1	-52.5	-16.1	-2	-27.5	-44	-25
Exchange rate effect	-1.9	2	-0.5	-0.3	0.9	0	-1.7	0.4	0	0.5
Net change in cash	-23.3	-0.3	0.8	-3.8	-8.8	4.9	6.5	-10.3	3.7	4.4
Free cash flow	4	28.3	50	-7.3	41.6	17	7.6	16.9	40.8	26.2
Interest paid	6.4	6.2	4.6	4.6	5.1	3.2	4	6.1	5.8	3.4
Income taxes paid	5.4	4.1	2.9	6.1	2.1	5.3	0.6	3.3	-1.2	6.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $17.25 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	24.8%	Gross profit / revenue.
Operating margin	7.0%	Operating income / revenue.
EBITDA margin	9.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.4%	Pre-tax income / revenue.
Net margin	2.2%	Net income / revenue.
FCF margin	4.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.2%	Cash from operations / revenue.
Effective tax rate	42.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.1%	Net income / average total assets.
Return on invested capital (ROIC)	5.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	1.4%	Research and development expense / revenue.
SG&A / revenue	13.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.6%	Capital expenditures / revenue.
D&A / revenue	2.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-1.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-3.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	4.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-2.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	2.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-20.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-18.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-3.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-15.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-16.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-4.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-58.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-34.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-17.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-58.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-34.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-17.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-33.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	28.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-7.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-35.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	51.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-8.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	3.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	6.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-3.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-3.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	1.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.33x	Current assets / current liabilities.
Quick ratio	0.96x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.14x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.26x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	15.0%	Total debt / total assets.
Liabilities / assets	42.8%	Total liabilities / total assets.
Net debt	$46.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.36x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	8.13x	Operating income / interest expense.
Working capital	$106.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	20.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$143.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.93x	Revenue / average total assets.
Fixed asset turnover	6.01x	Revenue / average property, plant and equipment.
Inventory turnover	2.68x	Cost of revenue / average inventory.
Days inventory	136 days	365 x average inventory / cost of revenue.
Receivables turnover	5.55x	Revenue / average receivables.
Days sales outstanding	66 days	365 x average receivables / revenue.
Days payables	40 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	162 days	Days inventory + days sales outstanding - days payables.
FCF conversion	210.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	35.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.29	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$13.25	Revenue / diluted weighted shares.
FCF per share	$0.62	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.96	Cash from operations / diluted weighted shares.
Book value per share	$8.32	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$5.36	Tangible book value / shares outstanding.
Cash per share	$0.43	(Cash + short-term investments) / shares outstanding.
Payout ratio	172.5%	Dividends paid / net income, when net income is positive.
Dividends / FCF	82.1%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	20.2%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$461.6M	Share price x shares outstanding.
Enterprise value	$508.4M	Market cap + total debt - cash - short-term investments.
P/E	57.7x	Market cap / net income. Only when net income is positive.
P/S	1.28x	Market cap / revenue.
P/B	2.07x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.22x	Market cap / tangible book value, when positive.
P/FCF	27.5x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	17.8x	Market cap / cash from operations, when positive.
EV/Sales	1.41x	Enterprise value / revenue.
EV/EBIT	20.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	30.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.6%	Free cash flow / market cap.
Earnings yield	1.7%	Net income / market cap (the inverse of P/E).
Dividend yield	3.0%	Dividends paid over the period / market cap.
Shareholder yield	3.7%	(Dividends paid + share buybacks) / market cap.

What was LUXFER HOLDINGS PLC's revenue in fiscal 2025?

LUXFER HOLDINGS PLC reported revenue of $384.6M for fiscal 2025, 1.9% lower than the year before.

Was LUXFER HOLDINGS PLC profitable in fiscal 2025?

Yes. Net income was $7.7M, a net margin of 2%.

How much free cash flow did LUXFER HOLDINGS PLC generate in fiscal 2025?

Cash from operations of $34.0M minus capital expenditures of $7.8M left free cash flow of $26.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LUXFER HOLDINGS PLC